Tình trạng nhiễm HIV, HBV, HCV và yếu tố liên quan ở một số nhóm nguy cơ cao tại Hà Nội, 2008 - 2010 - 19

Immigrants in Southern Italy", Hep. Research and Treatment Journal,

20(10), pp. 1-6.

185. Sharma, S. D. (2010), "Hepatitis C virus: Molecular biology & current therapeutic options", Indian of Med. Res. Journal, 131, pp. 17-34.

186. Shepard, C. W., Finelli, L. & Alter, M. J. (2005), "Global epidemiology of hepatitis C virus infection", The Lancet Infectious Diseases Journal, Vol. 5(9), pp. 558-567.

187. Shepard, C. W., Simard, E. P., Finelli, L. & al. (2006), "Hepatitis B virus infection: Epidemiology and Vaccination", Epidemiol. Rev. J., 28, pp. 112-125.

188. Sherman, M. (2009), "Strategies for managing coinfection with hepatitis B virus and HIV", Cleveland Clinic J. of Med., 76(3), pp. S30-S33.

189. Sherman, M. (2009), "Risk of hepatocellular carcinoma in hepatitis B and prevention through treatment", Cleveland Clinic. J. of Med., Vol. 76(3), pp. S6-S9.

190. Sievert, W. & al. (2011), "A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt", Livers International, pp. 61-79.

191. Solomon, S. S. & al. (2008), "High prevalence of HIV, HIV/hepatitis C virus co-infection and risk behaviors among IDUs in Chennai, India: A cause for concern", Acquir. Immune Defic. Sydr. J., 49(3), pp. 327-332.

Có thể bạn quan tâm!

• Tỷ Lệ Nhiễm Hiv, Hbv, Hcv Ở Nhóm Nghiện Chích Ma Túy, Phụ Nữ Bán Dâm , Bệnh Nhân Chạy Thận Nhân Tạo Và Bệnh Nhân Truyền Máu Nhiều Lần Ở Hà Nội (2008,
• Bihl, F., Castelli, D. & Al. (2007), "transfusion-Transmitted Infections",
• Tình trạng nhiễm HIV, HBV, HCV và yếu tố liên quan ở một số nhóm nguy cơ cao tại Hà Nội, 2008 - 2010 - 18

Xem toàn bộ 156 trang tài liệu này.

192. Sugiura, W., Matsuda, M. & al. (1999), "Prevalence of drugresistance-related mutations among HIV-1s in Japan", Jpn. Infect. Dis. J., 52, pp. 21-22.

193. Sulkowski, M. S. (2008), "Viral hepatitis and HIV coinfection",

Hepatol. Journal, 48 (2), pp. 353-67.

194. Sulkowski, M. S. (2008), "Management of hepatic complications in HIV-infected persons", Infect. Dis. J., 197 (3), pp. S279-93.

195. Sy, T. & Jamal, M. M. (2006), "Epidemiology of Hepatitis C Virus (HCV) Infection ", Int. J. Med. Sci. , 3, pp. 41-46.

196. Tan, Y., Wei, Q. H. & al. (2008), "Molercular Epidemiology of HCV monoinfection and HIV/HCV coinfection in Injection Drug Users in Liuzhou, Southern China", PLoS. One Journal, Vol. 3(10), pp. 1-7.

197. Taylor, B. S., Sobieszczyk, M. E. & McCutchan, F. E. (2008), "The Challenge of HIV-1 Subtype Diversity", N. Engl. Med. Journal, 358, pp. 1590-602.

198. Tee, K. K., Pon, C. K. & Kamarulzaman, A. (2005), "Emergence of HIV-1 CRF01_AE/B unique recombinant forms in Kuala Lumpur, Malaysia", AIDS J., 19, pp. 119-126.

199. Tencer, T. & al. (2007), "Medical costs and resource utilization for hemophilia patients with and without HIV or HCV infection", J. of Managed Care Pharmacy, Vol. 13(9), pp. 790-98.

200. Tenenbaum, S. A., Morris, C. A. & al. (2005), "Evidence of HIV exposure and transient seroreactivity in archived HIV-negative severe hemophiliac sera", Virology Journal, 2, pp. 64-65.

201. Thibault, V. & al. (2011), "Hepatitis C Transmission in Injection Drug Users: Could Swabs Be the Main Culprit? " Infect. Dis. Journal, 204, pp. 1839-42.

202. Thio, C. L. (2007), "Treatment of HIV/HBV Coinfection: Clinical and Virologic Issues", AIDS Reviews Journal, 9, pp. 40-53.

203. Thio, C. L. (2009), "Hepatitis B and Human Immunodeficiency Virus Coinfection", Hepatology journal, Vol. 49(5), pp. S139-S145.

204. Thomson, B. J. (2009), "Hepatitis C virus: the growing challenge",

British Med. Bull. Journal, 89, pp. 153-167.

205. Thomson, M. M. & Najara, R. (2005), "Molecular Epidemiology of HIV-1 Variants in the Global Aids Pandemic: an Update", AIDS Reviews Journal, 7, pp. 210-24.

206. Thu, A. N. & al. (2008), "A hidden HIV epidemic among women in Vietnam", BMC Public Health Journal, 8, pp. 37.

207. Todd, C. S., Nasir, A. & Stanekzai, M. R. (2011), "Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment", Harm Reduct. J., 8(22), pp. 1-8.

208. Tovanabutra, S., Beyrer, C. & Sakkhachomphop, S. (2004), "The changing molecular epidemiology of HIV type 1 among Thai drug users, 1999 to 2002", AIDS Res. Hum. Retroviruses J., 20, pp. 465-75.

209. Trinks, J., Gadano, A. & Argibay, P. (2012), "Evolving Trends in the Hepatitis C Virus Molecular Epidemiology Studies: From the Viral Sequences to the Human Genome", Hindawi Epi. Res. Intern. journal, Vol. 12, pp. 1-10.

210. UNAIDS (2008), Report on the Global AIDS epidemic, 2008. http://www.unaids.org accessed 09/15/08, UNAIDS, Geneva.

211. UNAIDS (2010), AIDS epidemic update December 2009. Global facts & figures, UNAIDS, Geneva.

212. Venook, A. P., Papandreou, C. & al. (2010), "The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective", Oncologist. Journal, 15(Suppl. 4), pp. 5-13.

213. Vlahov, D. & Robertson, A. M. (2010), "Prevention of HIV Infection among Injection Drug Users in Resource-Limited Settings", Clinical Infect. Dis. J., 50(S3), pp. S114-S121.

214. Wainberg, M. A. (2004), "HIV-1 subtype distribution and the problem of drug resistance", AIDS Journal, 18(3), pp. S63-S68.

215. Ward, J. W. (2008), "Time for Renewed Commitment to Viral Hepatitis Prevention", Public Health Am. Journal, Vol. 98(5), pp. 779-781.

216. Wasley, A. & al. (2010), "The prevalence of hepatitis B virus infection in the United States in the era of vaccination", Infect. Dis. Journal, 202(2), pp. 192-201.

217. Wecawiak, H. & Kamar, N. (2010), "Treatment of chronic hepatitis C virus Infection in Dialysis: An update", Hindawi P.C. Hep. Resear. and Treat. j., pp. 1-6.

218. Yu, M. L. & Chuang, W. L. (2009), "Treatment of chronic hepatitis C in Asia: When East meets West", J. of Gastr. and Hepatol., 24, pp. 336-345.

219. Yu, M. L., Dai, C. Y. & Huang, J. F. (2007), "A randomed study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C", Gut. J., 56, pp. 553-559.

220. Zarkesh, E. & al. (2010), "Hepatitis C virus genotype frequency in Isfahan province of Iran: a descriptive cross-sectional study", Virology J., 7, pp. 69.

221. Zarkoon, D. & al. (2008), "HepatitisC virus infection in patients on long term hemodialysis", Gomal of Med. Sc. Journal, Vol. 6(1), pp. 1-4.

222. Zein, N. N. (2000), "Clinical Significance of Hepatitis C virus Genotypes", Clinic. Microbiol. Reviews Journal, 13(2), pp. 223-235.

223. Zhou, J., Dore, G. J. & Zhang, F. (2007), "Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database", J. Gastr. Hepatol., Vol. 22(9 ), pp. 1510-8.